Secondary bacterial infection among snakebite victims Snake venom
Conditions
Interventions
Use of early empirical antibiotic therapy for Treatment of the secondary infection in the snakebite.The two groups will initially be hospitalized and followed for at least seven (7) days.
Experimental
Drug
N02.421.143.827.363
D03.438.810.835.322.186
Sponsors
Universidade do Estado do Amazonas
Fundação de Amparo à Pesquisa do Estado do Amazonas
Eligibility
Age
1 Years to 100 Years
Inclusion criteria
Inclusion criteria: To have less than 24 hours of the accident; did not to use any antibiotics before answering the institution; to have not done the antivenom for the current snakebite ; to have no abscess or infection clearly established at the time of admission ; not to be allergic to the antibiotic of choice in this study ; not to be pregnant and not accept participate.
Exclusion criteria
Exclusion criteria: have mental inability to understand the objectives of the study and participate in the survey; have acute or chronic unstable; unavailability of stay in hospital for seven days to follow.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of secondary infection snakebite by 50% for patients in the group treated with antibiotic therapy early - intervention group. The primary endpoint for the occurrence of infection understand the time of recruitment until 48 hours after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Determining a clinical score for bacterial infection and possible early detection for protocol establishment of the event by markers of laboratory tests and clinical outcome.The secondary outcome for the occurrence of infection comprise the period after 48 hours to 7 days after the intervention. | — |
Countries
Brazil
Contacts
Public ContactJacqueline Sachett
Universidade do Estado do Amazonas
Outcome results
None listed